2018
DOI: 10.1016/j.gene.2018.05.025
|View full text |Cite
|
Sign up to set email alerts
|

Dendrosomal nanocurcumin and exogenous p53 can act synergistically to elicit anticancer effects on breast cancer cells

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
9
0

Year Published

2019
2019
2024
2024

Publication Types

Select...
8
1

Relationship

1
8

Authors

Journals

citations
Cited by 14 publications
(9 citation statements)
references
References 69 publications
0
9
0
Order By: Relevance
“…Nano curcumin was purchased from Alborz Nano-drug Technology Company from Iran. For in vitro experiments, DNC was diluted in complete culture medium (DMEM) at different concentrations (0.25–10 μM) using an optimized protocol which has been set up in our lab [ 20 22 , 42 ]. In Brief, different weight/weight ratios of dendrosome/curcumin were analyzed leading to the establishment of an appropriate ratio of 25:1.…”
Section: Methodsmentioning
confidence: 99%
See 1 more Smart Citation
“…Nano curcumin was purchased from Alborz Nano-drug Technology Company from Iran. For in vitro experiments, DNC was diluted in complete culture medium (DMEM) at different concentrations (0.25–10 μM) using an optimized protocol which has been set up in our lab [ 20 22 , 42 ]. In Brief, different weight/weight ratios of dendrosome/curcumin were analyzed leading to the establishment of an appropriate ratio of 25:1.…”
Section: Methodsmentioning
confidence: 99%
“…However, the inherent limitations of the compound itself, such as hydrophobicity, instability, poor absorption and rapid systemic elimination, imposes a hurdle for translation to wider clinical applications [ 18 , 19 ]. To overcome this major barrier and enhancing half-life and cellular permeability of curcumin, we employed an amphipathic and biodegradable nanocarrier which was previously synthesized by our group called dendrosomal nanocurcumin (DNC) [ 20 22 ].…”
Section: Introductionmentioning
confidence: 99%
“…Triple-negative breast cancer (TNBC) is one of the most important histological subtypes of breast cancers having a metastatic phenotype. It has been demonstrated that dendrosomal nanocurcumin and exogenous p53 can act together to produce anticancer effects against TNBC cells (Baghi et al, 2018). HIF-1 and NF-kB are both indispensable for the improvement of cancer cell progression.…”
Section: Anticancer Effectsmentioning
confidence: 99%
“…Besides translation factors, downstream of HIF-1α, curcumin markedly affects the expression of EMT TFs such as Twist (Kim et al, 2013), and Snail (Lee et al, 2015). Finally, Bagui et al (2018) reported that triple-negative breast cancer cells, which exhibited aberrant activity of EMT, were characterized by their reduced expression of zinc finger E-box-binding homeobox 1 (ZEB1) after treatment with a nanoformulation of curcumin (Figure 3).…”
Section: Molecular and Cellular Cancer Emt: Targets Of Curcuminoidsmentioning
confidence: 98%